GRI Bio, Inc. (NASDAQ:GRI) filed a Form 8-K with the Securities and Exchange Commission on January 21, 2026, disclosing a material event.
GRI Bio, Inc.'s stock currently trades at $0.22 with a market capitalization of $1.3M. The Healthcare company's stock moved following the disclosure.
